Accumulation of intracellular sorbitol, the reduced product of glucose
, catalyzed by aldose reductase (AR) (EC 1.1.1.21), is thought to be t
he cause of the development of diabetic complications. Our attention i
s focused on finding compounds which inhibit AR without significantly
inhibiting aldehyde reductase (ALR) (EC 1.1.1.2). The uracil or 2,4-di
oxoimidazolidine skeleton having the benzothiazolyl or 4-chloro-3-nitr
ophenyl group as an aryl part indicated not only extremely high AR inh
ibitory activity but also AR selectivity. The ratio of IC50(ALR)/IC50(
AR) of ]-1,2,3,4-tetrahydro-2,4-dioxopyrim-idine-1-acetic acid (47d) w
as more than 17 500. The uracil skeleton with the benzothiazolyl moiet
y seemed to be the best combination for selective AR inhibition.